ArticleCureus2024
Tube Insertion of Ahmed Glaucoma Valve Using a Micro-incision Scleral Tunnel Technique.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Article
- Impact of prostaglandin-associated periorbitopathy on surgical outcomes of trabeculectomy and ahmed glaucoma valve implantation.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025Article
- Scleral tunneling combined with the Tenon's capsule coverage in Glaucoma Drainage Valve surgery.BMC ophthalmology · 2025Article
- A Case of Long-Term Undiagnosed Cyclodialysis Cleft Following Tanito Microhook Trabeculotomy.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report three cases demonstrating the efficacy and versatility of the micro-incision scleral tunnel (MIST) technique, a novel method for Ahmed glaucoma valve (AGV) tube insertion. MIST is characterized by its small incision, sutureless approach, anterior-to-posterior tunnel creation, and allograft-free design. The technique involves creating a scleral tunnel using a 1-mm crescent knife (Bleb Knife II), allowing for secure tube placement into the anterior chamber, ciliary sulcus, or vitreous cavity. Case 1 involved a male patient in his 70s with primary angle-closure glaucoma, where the tube was inserted into the vitreous cavity. Pars plana vitrectomy was combined, achieving an intraocular pressure (IOP) of 6 mmHg without medication at three months postoperatively. Case 2 described a male patient in his 70s with secondary angle-closure glaucoma due to iridocyclitis, where the tube was inserted into the ciliary sulcus. Postoperatively, the IOP was reduced to 7 mmHg without medication at three months. Case 3 was a male patient in his teens with Axenfeld-Rieger syndrome-associated glaucoma, who underwent anterior chamber tube insertion, achieving an IOP of 8 mmHg with two medications at eight months postoperatively. In addition, postoperative anterior segment findings for the other two cases were presented. These cases demonstrate that MIST simplifies surgical procedures, eliminates the need for suturing, and achieves effective IOP control. The flexibility and promising outcomes of MIST suggest its potential as an alternative technique for tube insertion in allograft-free glaucoma tube shunt surgeries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.